Status:
COMPLETED
The Study to Describe Symptom Control and Impact on Daily Life in Gastroesophageal Reflux Disease (GERD) Patients
Lead Sponsor:
AstraZeneca
Conditions:
Gastroesophageal Reflux Disease
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to evaluate symptoms control and impact on daily life from patients perspective using specific GERD Impact Scale(GIS) questionnaire. The another objective is to obtain loc...
Eligibility Criteria
Inclusion
- Patients previously diagnosed with GERD (disease duration =3 years) or newly diagnosed patients that are currently not treated with proton pump inhibitor, for whom specialist or General Practionaire (GP) have previously decided to initiate or change treatment for GERD; Patients should be treated for GERD according to current practice
Exclusion
- Females of childbearing potential should not be pregnant or nursing
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
1233 Patients enrolled
Trial Details
Trial ID
NCT01200550
Start Date
September 1 2010
End Date
November 1 2011
Last Update
April 17 2012
Active Locations (23)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Banja Luka, Bosnia and Herzegovina
2
Research Site
Bijeljina, Bosnia and Herzegovina
3
Research Site
Derventa, Bosnia and Herzegovina
4
Research Site
Doboj, Bosnia and Herzegovina